Laurentis fuels future of cancer care in Ontario with $500k donation to Princess Margaret Cancer Foundation

Key facts 

• Laurentis, a subsidiary of Ontario Power Generation (OPG), is North America’s most diverse and fastest-growing medical isotope producer.
• UHN is Canada’s hospital, with 10 sites and more than 44,000 TeamUHN members.
• Laurentis recently announced it’s set to begin producing therapeutic isotopes Y-90 and Lu-177 at OPG’s Darlington Nuclear Generating Station.

• • Lu-177 is one of the fastest-growing therapeutic isotopes on the market, used in treating prostate, breast, and neuroendocrine cancers.
  • Laurentis could produce enough Lu-177 at Darlington to supply nearly 3 million doses, enough to fully treat 500,000 patients each year, vastly increasing the global supply capacity.
  • Y-90 plays a critical role in liver cancer treatment, one of the top causes of cancer death globally.

• The new Silber Family Theranostics Centre aims to deliver 3,550 treatments annually by 2028.
• Life-saving medical isotopes continue to be one of the most consequential tools doctors have available to diagnose and treat cancer over the past century, and many of these isotopes are now coming from Ontario’s nuclear generating stations.

Quotes

“Ontario’s nuclear advantage is saving lives. We’re harnessing the power of made-in-Ontario isotopes to fuel next generation cancer care – giving patients more hope, delivering faster diagnoses and providing more effective treatments. At the same time, we’re creating good-paying jobs, strengthening our economy and showcasing Ontario’s energy leadership on the world stage”.
- Stephen Lecce, Ontario Minister of Energy and Mines

“Our government is protecting Ontario’s healthcare system and giving people access to more innovative treatment options by expanding access to life-saving medications and treatments. Laurentis’s donation to help establish the Silber Family Theranostics Centre at Princess Margaret Cancer Centre will drive Ontario-made innovation and connect more people to world-class cancer care, close to home."
- Sylvia Jones, Deputy Premier of Ontario and Minister of Health

"Advancements in medical isotope production are revolutionizing the way patients across our province are able access next-generation treatments. This initiative, supported by the generosity of Laurentis Energy Partners, will further the ambitions set out by our government’s Life Sciences Strategy and ensure Ontario can continue to lead in the development of consequential diagnostic tools and innovative breakthroughs for use at home, and around the world."
- Vic Fedeli, Minister of Economic Development, Job Creation and Trade

"Ontario is proudly home to a world-class sector of isotope researchers that drive critical cancer discoveries and saves the lives of people across our province. Our government welcomes Laurentis’s investment to establish the Silber Family Theragnostic Centre, which will further the province’s production of life-saving cancer treatments through homegrown isotope research, improving patient outcomes and further cementing Ontario as a global leader in medical research."
- Nolan Quinn, Minister of Colleges, Universities, Research Excellence and Security

"At Laurentis, we’re driven by the real-world impact of our work on patients. Supporting the development of Princess Margaret’s Silber Family Theranostics Centre means advancing access to more precise and effective cancer treatments for patients in need. As one of the world’s leading producers of medical isotopes, Laurentis is proud to help power these critical therapies with materials made right here in Ontario."
- Leslie McWilliams, President and CEO, Laurentis

"OPG’s nuclear fleet is powering Ontario’s homes and businesses while also making a global impact on health care by producing and innovating in the field of medical isotopes. We are so fortunate to have the Princess Margaret Cancer Centre – a world-renowned cancer research and treatment centre – right here in Ontario. We are proud to support the Princess Margaret Cancer Centre’s ground-breaking work, which is making a real difference in the lives of patients, improving outcomes for more Ontarians."
- Nicolle Butcher, OPG President and CEO